Hyperfine Q3 GAAP EPS of -$0.06 beats by $0.02; revenue of $5.96M misses by $0.75M

Hyperfine reported Q3 GAAP EPS of -$0.06, beating estimates by $0.02, with revenue of $5.96M, missing by $0.75M. The company's net loss narrowed to $5.98M from $11.02M year-over-year, and operating loss decreased by 19%.

Original reporting
Published Nov 17, 2026, 2:32 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 17, 2026, 2:35 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Hyperfine Q3 GAAP EPS of -$0.06 beats by $0.02; revenue of $5.96M misses by $0.75M — source image
Decision brief

The 30-second read

$HYPRNeutralLow
01

Why it matters

This is a straightforward earnings-print recap with no additional forward-looking guidance or deal information in the provided text.

02

Market read

Traders may reassess near-term fundamentals based on the beat/miss and loss narrowing, but the lack of guidance limits decision impact.

03

What to watch

The brief does not include guidance, cash balance, or backlog details, which are often the real drivers after a revenue miss.

Relevance 4/10Novelty 2/10Timing: reported in the afternoon, after the prior quarter’s release

Background

The article summarizes Hyperfine’s Q3 results, noting EPS beat and revenue miss, plus narrowing GAAP net loss versus the prior year quarter.

Company-level read

Ticker impact

$HYPRNeutralMedium confidence
Context

Hyperfine reported Q3 GAAP EPS of -$0.06 and revenue of $5.96M, with EPS beating and revenue missing by stated amounts.

Expected impact

Likely mixed reaction, with pressure from the revenue miss offset by the EPS beat.

Evidence & confidence

The article provides the company’s own quarterly results with explicit beat/miss figures, but no guidance or new catalyst beyond the print.

Market effects

Limited read-through to the broader medical device or diagnostics space because the article contains only a single-company quarterly print.

No clear regional spillover beyond US small-cap biotech/healthtech sentiment.

Minimal global relevance; no international regulatory or partnership developments mentioned.

Counterpoint

If investors focus on narrowing GAAP net loss and operating loss, the EPS beat could outweigh the revenue miss for valuation support.

Key entities

  • Hyperfine

    HYPR, reported Q3 GAAP EPS and revenue, with losses narrowing year over year.

Related articles

$HYPRMed

What Hyperfine (HYPR) Said on Its Q3 Earnings Call

Hyperfine (HYPR) reported $13.8M revenue for the first nine months, up 66% YoY, with 36 systems sold. Management maintained its revenue forecast, citing capital equipment deal sizes and visibility. The company discussed its 'land-and-expand' strategy in health systems and progress in contrast imaging studies. Hyperfine also expanded internationally and explored new markets like memory clinics and wellness.

$HYPRMed

Hyperfine, Inc. Reports Third Quarter 2026 Financial Results

Hyperfine, Inc. (HYPR) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Hyperfine, Inc. Reports Third Quarter 2026 Financial Results GUILFORD, Conn.--(BUSINESS WIRE)--November 9, 2026--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portab

$HYPRMedAI 9/10

Hyperfine expects Q3 revenue of $6M; shares jump 9%

Hyperfine HYPR reported preliminary Q3 2026 revenue of $6.0M, beating estimates and up 53% sequentially. Shares rose 9% premarket. Net cash burn improved 29% QoQ. Full-year revenue guidance remains $20M-$22M, with cash burn expected to decline 10% YoY. Results will be detailed on Nov 9, 2026.

$HYPRMed

Hyperfine Reports Record Preliminary Third Quarter Revenue of Approximately $6.0 Million & Reaffirms Full Year 2026 Revenue Outlook of Approximately $20 to…

Hyperfine, Inc. (HYPR) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Hyperfine Reports Record Preliminary Third Quarter Revenue of Approximately $6.0 Million & Reaffirms Full Year 2026 Revenue Outlook of Approximately $20 to $22 Million Preliminary Revenue Represents 53% Sequential Quarterly Growth; Company Reaffirms 2026 Financial Gu

$HYPRMedAI 8/10

Hyperfine (HYPR) Q2 2026 Earnings Call Transcript

Hyperfine (HYPR) reported Q2 2026 revenue of $3.9 million, up 45% year over year, and first-half revenue of $7.8 million, up 62%. Gross margin was 50.7%. Net loss was $9.3 million. Cash was $43.5 million at June 30, 2026. Full-year 2026 guidance: revenue $20-$22 million, gross margin 50%-55%, cash burn $26-$28 million.